Found: 18
Select item for more details and to access through your institution.
Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?
- Published in:
- Expert Opinion on Pharmacotherapy, 2023, v. 24, n. 8, p. 887, doi. 10.1080/14656566.2023.2201373
- By:
- Publication type:
- Article
Standard Versus Reduced CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: An Observational Multicenter Study.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 23, p. 7441, doi. 10.3390/jcm13237441
- By:
- Publication type:
- Article
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review.
- Published in:
- Cancers, 2024, v. 16, n. 23, p. 4082, doi. 10.3390/cancers16234082
- By:
- Publication type:
- Article
Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?
- Published in:
- Medical Oncology, 2013, v. 30, n. 2, p. 1, doi. 10.1007/s12032-013-0578-8
- By:
- Publication type:
- Article
Stand der Forschung und neue therapeutische Perspektiven in der Immuntherapie des Prostatakarzinoms.
- Published in:
- Kompass Onkologie, 2023, v. 10, n. 3, p. 122, doi. 10.1159/000533206
- By:
- Publication type:
- Article
Evaluating CDK4/6 Inhibitor Therapy in Elderly Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer: A Retrospective Real-World Multicenter Study.
- Published in:
- Cancers, 2024, v. 16, n. 20, p. 3442, doi. 10.3390/cancers16203442
- By:
- Publication type:
- Article
Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 654, doi. 10.3390/cancers15030654
- By:
- Publication type:
- Article
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 4028, doi. 10.3390/cancers14164028
- By:
- Publication type:
- Article
Metronomic chemotherapy with cyclophosphamide plus low dose of corticosteroids in advanced castration-resistant prostate cancer across the era of taxanes and new hormonal drugs.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
- Published in:
- Life (2075-1729), 2023, v. 13, n. 7, p. 1482, doi. 10.3390/life13071482
- By:
- Publication type:
- Article
Antibody–Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 23, p. 7325, doi. 10.3390/jcm12237325
- By:
- Publication type:
- Article
The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 18, p. 6012, doi. 10.3390/jcm12186012
- By:
- Publication type:
- Article
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)‐ERIBE.
- Published in:
- Oncologist, 2019, v. 24, n. 6, p. e232, doi. 10.1634/theoncologist.2017-0676
- By:
- Publication type:
- Article
Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside.
- Published in:
- Biology (2079-7737), 2024, v. 13, n. 6, p. 409, doi. 10.3390/biology13060409
- By:
- Publication type:
- Article
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.
- Published in:
- Current Oncology, 2023, v. 30, n. 6, p. 5769, doi. 10.3390/curroncol30060432
- By:
- Publication type:
- Article
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?
- Published in:
- Breast Journal, 2020, v. 26, n. 9, p. 1857, doi. 10.1111/tbj.13856
- By:
- Publication type:
- Article
Synergizing Immunotherapy and Antibody–Drug Conjugates: New Horizons in Breast Cancer Therapy.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 9, p. 1146, doi. 10.3390/pharmaceutics16091146
- By:
- Publication type:
- Article
The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 6, p. 1604, doi. 10.3390/pharmaceutics15061604
- By:
- Publication type:
- Article